329 related articles for article (PubMed ID: 23397032)
41. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
[TBL] [Abstract][Full Text] [Related]
42. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro.
Saleh H; Eeles D; Hodge JM; Nicholson GC; Gu R; Pompolo S; Gillespie MT; Quinn JM
Endocrinology; 2011 May; 152(5):1911-22. PubMed ID: 21363931
[TBL] [Abstract][Full Text] [Related]
43. Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor.
Rauch A; Seitz S; Baschant U; Schilling AF; Illing A; Stride B; Kirilov M; Mandic V; Takacz A; Schmidt-Ullrich R; Ostermay S; Schinke T; Spanbroek R; Zaiss MM; Angel PE; Lerner UH; David JP; Reichardt HM; Amling M; Schütz G; Tuckermann JP
Cell Metab; 2010 Jun; 11(6):517-31. PubMed ID: 20519123
[TBL] [Abstract][Full Text] [Related]
44. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
[TBL] [Abstract][Full Text] [Related]
45. Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts.
Viereck V; Gründker C; Friess SC; Frosch KH; Raddatz D; Schoppet M; Nisslein T; Emons G; Hofbauer LC
J Bone Miner Res; 2005 Nov; 20(11):2036-43. PubMed ID: 16234977
[TBL] [Abstract][Full Text] [Related]
46. The PERK-EIF2α-ATF4 signaling branch regulates osteoblast differentiation and proliferation by PTH.
Zhang K; Wang M; Li Y; Li C; Tang S; Qu X; Feng N; Wu Y
Am J Physiol Endocrinol Metab; 2019 Apr; 316(4):E590-E604. PubMed ID: 30668150
[TBL] [Abstract][Full Text] [Related]
47. Lrp6 is a target of the PTH-activated αNAC transcriptional coregulator.
Pellicelli M; Hariri H; Miller JA; St-Arnaud R
Biochim Biophys Acta Gene Regul Mech; 2018 Feb; 1861(2):61-71. PubMed ID: 29413898
[TBL] [Abstract][Full Text] [Related]
48. Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism.
Bellido T; Ali AA; Plotkin LI; Fu Q; Gubrij I; Roberson PK; Weinstein RS; O'Brien CA; Manolagas SC; Jilka RL
J Biol Chem; 2003 Dec; 278(50):50259-72. PubMed ID: 14523023
[TBL] [Abstract][Full Text] [Related]
49. gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation.
Standal T; Johnson RW; McGregor NE; Poulton IJ; Ho PW; Martin TJ; Sims NA
J Endocrinol; 2014 Nov; 223(2):181-90. PubMed ID: 25228504
[TBL] [Abstract][Full Text] [Related]
50. The effects of prostaglandin E2, parathyroid hormone, and epidermal growth factor on mitogenesis, signaling, and primary response genes in UMR 106-01 osteoblast-like cells.
Fang MA; Kujubu DA; Hahn TJ
Endocrinology; 1992 Nov; 131(5):2113-9. PubMed ID: 1330491
[TBL] [Abstract][Full Text] [Related]
51. Parathyroid hormone increases activating transcription factor 4 expression and activity in osteoblasts: requirement for osteocalcin gene expression.
Yu S; Franceschi RT; Luo M; Zhang X; Jiang D; Lai Y; Jiang Y; Zhang J; Xiao G
Endocrinology; 2008 Apr; 149(4):1960-8. PubMed ID: 18187540
[TBL] [Abstract][Full Text] [Related]
52. Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages.
Isogai Y; Akatsu T; Ishizuya T; Yamaguchi A; Hori M; Takahashi N; Suda T
J Bone Miner Res; 1996 Oct; 11(10):1384-93. PubMed ID: 8889836
[TBL] [Abstract][Full Text] [Related]
53. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
54. Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway.
Chen Z; Xue J; Shen T; Mu S; Fu Q
Int J Mol Med; 2016 Feb; 37(2):329-38. PubMed ID: 26677102
[TBL] [Abstract][Full Text] [Related]
55. Increased expression of tissue plasminogen activator messenger ribonucleic acid is an immediate response to parathyroid hormone in neonatal rat osteoblasts.
Catherwood BD; Titus L; Evans CO; Rubin J; Boden SD; Nanes MS
Endocrinology; 1994 Mar; 134(3):1429-36. PubMed ID: 8119183
[TBL] [Abstract][Full Text] [Related]
56. Parathyroid hormone induces c-fos and c-jun messenger RNA in rat osteoblastic cells.
Clohisy JC; Scott DK; Brakenhoff KD; Quinn CO; Partridge NC
Mol Endocrinol; 1992 Nov; 6(11):1834-42. PubMed ID: 1480173
[TBL] [Abstract][Full Text] [Related]
57. Mangiferin inhibits apoptosis and oxidative stress via BMP2/Smad-1 signaling in dexamethasone-induced MC3T3-E1 cells.
Ding LZ; Teng X; Zhang ZB; Zheng CJ; Chen SH
Int J Mol Med; 2018 May; 41(5):2517-2526. PubMed ID: 29484386
[TBL] [Abstract][Full Text] [Related]
58. Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts.
Li X; Qin L; Bergenstock M; Bevelock LM; Novack DV; Partridge NC
J Biol Chem; 2007 Nov; 282(45):33098-106. PubMed ID: 17690108
[TBL] [Abstract][Full Text] [Related]
59. Prostaglandin-mediated inhibition of PTH-stimulated β-catenin signaling in osteoblasts by bone marrow macrophages.
Estus TL; Choudhary S; Pilbeam CC
Bone; 2016 Apr; 85():123-30. PubMed ID: 26851123
[TBL] [Abstract][Full Text] [Related]
60. Amphiregulin-EGFR signaling mediates the migration of bone marrow mesenchymal progenitors toward PTH-stimulated osteoblasts and osteocytes.
Zhu J; Siclari VA; Liu F; Spatz JM; Chandra A; Divieti Pajevic P; Qin L
PLoS One; 2012; 7(12):e50099. PubMed ID: 23300521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
